As a leader for contract development and manufacturing, Lonza is recognized for reliable, high-quality services, global capacity, innovative technology platform and extensive experience. We serve pharmaceutical and biotechnology companies globally striving to help reduce risk and increase chances of business success. Our broad capabilities span across biologics, small molecules, bioconjugates and cell and gene therapies; for projects ranging from pre-clinical stage through to commercialization, for both drug-substance and -product.


BioMed Realty, a Blackstone portfolio company, is a leading provider of real estate solutions to the life science and technology industries. As of December 31, 2020, BioMed owns and operates high quality life science real estate comprising 13.1 million square feet concentrated in leading innovation markets throughout the United States and United Kingdom, including Boston/Cambridge, San Francisco, San Diego, Seattle and Cambridge, U.K. In addition, BioMed maintains a premier development platform with 3.0 million square feet of Class A properties in active construction to meet the growing demand of the life science industry. 

The delivery of personalized healthcare is causing a power shift with new entrants disrupting incumbents. Innovation, productivity and access to patients challenge every link in the life sciences value chain, from R&D and product supply to product launch and patient-centric operating models.

EY Life Sciences brings together a worldwide network of 23,000 sector professionals to anticipate trends, identify implications and help clients create competitive advantage in a health outcomes-driven ecosystem.



Jennifer Brown, Managing Director | Email Jennifer | 858 535 7208
Dan Kleeburg, Partner | Email Dan | 858 535 7209

Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at lilly.com and lilly.com/newsroom.



Merck & Co., Inc., Kenilworth, New Jersey, USA is known as MSD outside of the United States and Canada.

Merck has a strong history of success in translating cutting-edge research into life-saving medical breakthroughs. With more than 100 significant business development transactions since 2017, our team has experience working on collaborations from discovery through clinical-stage programs.  

We believe that by working together we can play a major role in transforming global health care.  Together we can invent for life.  Learn more at msdlicensing.com.

The future of life sciences is in data, and no firm is better situated than MoFo to understand the convergence of the life sciences industry and data analytics. Our Life Sciences Group advises clients on all legal aspects of life sciences data analytics businesses, including patenting software and AI-related life science inventions, licensing of data, providing counsel on the steps to ensure data privacy and ethical use of data, and guiding clients through the FDA approval process for data-driven diagnostic assays and medical devices. Our Life Sciences Group is a unique amalgamation of lawyers with extensive training in biotechnology and pharmaceuticals coupled with the cutting-edge application of data science. We apply this combination for our digital health, biotechnology, medical device, pharmaceutical, and agtech clients, bridging the gap between the law and science.








Perkins Coie has built a premier law firm by immersing ourselves in our clients’ technologies. Whether building strategic patent portfolios or prosecuting, guiding regulatory compliance, or defending and enforcing quality patents that consistently withstand challenges, we represent life sciences leaders and emerging innovators. We also help create new opportunities steering clients’ venture capital financings, IPOs, licensing agreements and other defining transactions. A number of our attorneys have advanced degrees in science or engineering. 



  • Mark Wicker, Partner, Technology Transactions & Privacy, San Diego Office | Contact Mark
  • Stephen Ferruolo, Partner, Technology Transactions & Privacy, San Diego Office | Contact Stephen

Wilson Sonsini’s life sciences practice offers a multi-disciplinary team of attorneys, patent agents, and scientific advisors. Our professionals work with scientists, entrepreneurs, and investors who have helped develop innovative discoveries in nearly every field of medicine and healthcare, from genomics, immuno-oncology and pharmaceuticals, to diagnostics and synthetic biology. We represent clients in a wide range of strategic and operational corporate areas and help them with complex commercial and tech transactions driven by IP and innovation.


Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com


Amgen Business Development creates opportunities that leverage our unique capabilities with innovative technologies and therapies of our partners to deliver life changing therapies for patients with serious illnesses. By bringing together deep scientific, financial, deal, partnership, and integration expertise, Business Development plays a critical role in the execution of Amgen’s growth strategy and effectively manages the process of working with partners, from funding early-stage innovation to integration and alliance management once an agreement is executed. Resource Links



Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. 

For more: www.bayer.com.

BioCentury helps C-level biotech executives and investors make business critical decisions by providing independent deep-dive analysis, high-quality data, and business intelligence on a global scale. We report on and dissect trends before others, helping you to better position your company for change and to capitalize on that change before your competition. No matter where you are in the drug development process—from idea to patient—we help you answer critical questions, decipher strategic trends, objectively evaluate product and business strategies, and assess competitive, financial, and policy risks. For more information, please visit BioCentury.com.

Request complimentary access to BioCentury Intelligence or BioCentury’s BCIQ Database https://go.biocentury.com/Biocom21.html

Blue Rise Ventures is a multi-asset class commercial real estate investment firm focusing on life science properties. The Blue Rise team offers diverse real estate experience in leasing, construction management, acquisitions, and asset management. A vertically integrated team allows Blue Rise to move swiftly and nimbly across leasing and construction to offer unparalleled support to prospective tenants. With several million square feet under management across the San Francisco Bay Area and strong ties to the region, Blue Rise Ventures seeks to build upon its strong relationships and expertise to continue to support our tenants.

Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. We provide innovative products and services in more than 20 countries around the world. With more than 100 years of scientific expertise, our company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients. Through the outstanding knowledge and commitment of our 15,000 employees worldwide, we create innovative new and generic medicines, and new methods of drug discovery and delivery. We share a passion for innovation, as well as compassion for the patients around the world who are in need of our medicines.


Genentech, a member of the Roche Group, discovers, develops, manufactures and commercializes medicines for patients with serious and life-threatening medical conditions. We are a leading biotech company, with ~40 approved medicines and a promising pipeline.  
Our Pharma Partnering team provides business development and alliance management support for Roche and Genentech’s R&D units and broader pharmaceutical division. Alongside our robust internal pipeline, external innovation has always been a critical component of our R&D strategy. 

Halloran Consulting Group is a life science consulting firm that provides strategic regulatory, quality, clinical, and organizational support to industry leaders and startup visionaries in the pharmaceutical, biotechnology, and medical device sectors. Our consultants are subject matter experts who deliver a tailored approach to each engagement, successfully propelling our clients to their next inflection point. We connect clients with our trusted industry partners to drive operational excellence and innovation throughout their organizations. Our aim is to support our clients, and the patients they serve.

Yokohama City is the second largest city in Japan and has promoted innovation in the life sciences over the past 30 years. Through the Kanazawa Bio Park and nearby universities, Yokohama has invested heavily in building an advanced R&D infrastructure, attracting major Japanese and international players, while also building out its support for entrepreneurs through its global startup ecosystem. Today, Yokohama is one of Japan’s liveliest life science R&D hubs. 

Learn more:  Yokohama’s Life Science Ecosystem 

Torreya is a global investment banking boutique serving companies in the life sciences industry. Since our inception in 2007, we have advised clients on more than $100 billion worth of deals for biotechnology, branded pharmaceutical, generic pharmaceutical, and life sciences companies. Our partners are senior industry bankers and executives, with deep experience, knowledge, and networks. We are a partner of choice for companies seeking discreet, conflict-free, and knowledgeable advice on M&A, pharmaceutical asset sale, capital markets, and licensing transactions. 



AbCellera is a technology company with an antibody discovery platform that searches and analyzes immune systems to find antibodies that can be used to prevent and treat disease. AbCellera’s technology, which combines high-throughput microfluidics, hyper-scale data science, machine learning, bioinformatics, and genomics, identifies new drug candidates and aims to reduce the time it takes to bring treatments to the clinic. AbCellera’s partners include leading biotechs, global health organizations, and many of the top 10 biopharmaceutical companies.


Bench International is the oldest woman-founded executive search firm serving the Life Science and Healthcare sectors. The firm is also one of the most renowned experts in diversity recruitment at the board and executive level, as well as in R&D leadership. Bench’s scorecard reflects over $150 billion in successful client exits, a 98% project completion record, with a 75% retention for five or more years. 33% of all leaders placed in Bench’s 45+ year history have been gender and ethnically diverse.


Catalent offers a broad array of analytical services to support rapid product development, including: stability testing and storage, organics, extractables and leachables, metals testing, solid-state screening, microbiology, compendial services and methods development and validation. With extensive capabilities, Catalent provides a one-stop solution to help bring your product to market, faster.


Early Phase Brochure 
Manufacturing Brochure 

Donnelley Financial Solutions works with public and private companies in the Pharma and Biotech space, helping them manage secure content related to financing, licensing, partnering, and M&A transactions via our virtual data room platform.



Engine Room provides comprehensive finance and accounting support to the West Coast’s smartest venture-backed life science and tech start-ups. Our work extends from detailed execution to CFO-caliber strategic guidance. We make sure every aspect of our client’s financial organization is cleanly structured, so they avoid critical mistakes, nail milestones and realize their vision.

Engine Room delivers:

  • Deep, specialized knowledge of life science start-ups
  • Insurance against critical start-up mistakes
  • CFO-level strategic guidance
  • Precise accounting execution
  • Ultra-efficient systems and processes
  • Scalability and affordability


McDermott Will & Emery is the nation’s leading health law firm. The Health Industry Advisory group is the only health practice to receive top national rankings from U.S. News – Best Lawyers “Best Law Firms,” Chambers USA, The Legal 500 US, and Law360. The practice was also recognized by Chambers as “Health Team of the Year” in 2010, 2013, 2017 and 2019. McDermott has held the top spot in PitchBook’s League Tables as the most active firm for healthcare private equity since 2017.

McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.